These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 18401919)

  • 41. Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?
    Bhutani M; Pathak AK
    J Natl Cancer Inst; 2008 Sep; 100(18):1334; author reply 1334-5. PubMed ID: 18780866
    [No Abstract]   [Full Text] [Related]  

  • 42. [Malignant lymphoma--there are still many open questions].
    Buske C; Hiddemann W
    Internist (Berl); 2007 Apr; 48(4):349-50. PubMed ID: 17361404
    [No Abstract]   [Full Text] [Related]  

  • 43. [Indication of chemotherapy according to histological type of musculoskeletal sarcomas].
    Goto T; Okuma T; Ogura K; Imanishi J; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):199-203. PubMed ID: 19223736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of radiological and pathohistological response to neoadjuvant chemotherapy combined with regional hyperthermia (RHT) and study of response dependence on the applied thermal parameters in patients with soft tissue sarcomas (STS).
    Stahl R; Wang T; Lindner LH; Abdel-Rahman S; Santl M; Reiser MF; Issels RD
    Int J Hyperthermia; 2009 Jun; 25(4):289-98. PubMed ID: 19670096
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials.
    Coleman RL;
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S77-80. PubMed ID: 18584855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Innovations in chemotherapy for metastatic colorectal cancer: an update of recent clinical trials.
    O'Neil BH; Goldberg RM
    Oncologist; 2008 Oct; 13(10):1074-83. PubMed ID: 18922828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of malignant pleural mesothelioma--present status and future view].
    Yano T; Morodomi Y; Ito K; Miura N; Takenaka T; Kawano D; Shoji F; Maehara Y
    Fukuoka Igaku Zasshi; 2008 Apr; 99(4):74-9. PubMed ID: 18646592
    [No Abstract]   [Full Text] [Related]  

  • 48. Seduction by induction?
    Beitler JJ; Cooper JS
    J Clin Oncol; 2009 Jan; 27(1):9-10. PubMed ID: 19047301
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical trials in adult AML.
    Stock W
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):8-10. PubMed ID: 19645130
    [No Abstract]   [Full Text] [Related]  

  • 50. Bevacizumab: new indication. Metastatic breast cancer: many adverse effects.
    Prescrire Int; 2008 Dec; 17(98):236. PubMed ID: 19422148
    [No Abstract]   [Full Text] [Related]  

  • 51. Tandem high-dose chemotherapy followed by autologous transplantation in patients with locally advanced or metastatic sarcoma.
    Lashkari A; Chow WA; Valdes F; Leong L; Phan V; Twardowski P; Kapoor N; Molina A; Al-Kadhimi Z; Frankel P; Somlo G
    Anticancer Res; 2009 Aug; 29(8):3281-8. PubMed ID: 19661346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perioperative chemotherapy for urothelial cancer: how have we made a "sow's ear" out of a chemotherapy-sensitive tumor?
    Dorff TB; Quinn DI
    Cancer; 2009 Nov; 115(22):5139-42. PubMed ID: 19645028
    [No Abstract]   [Full Text] [Related]  

  • 53. Overcoming challenges associated with chemotherapy treatment in the senior adult population.
    Droz JP; Aapro M; Balducci L
    Crit Rev Oncol Hematol; 2008 Oct; 68 Suppl 1():S1-8. PubMed ID: 18752969
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Osteosarcoma: the same old drugs or more?
    Bielack SS; Marina N; Ferrari S; Helman LJ; Smeland S; Whelan JS; Reaman GH
    J Clin Oncol; 2008 Jun; 26(18):3102-3; author reply 3104-5. PubMed ID: 18565904
    [No Abstract]   [Full Text] [Related]  

  • 55. Response assessment in clinical trials: implications for sarcoma clinical trial design.
    Jaffe CC
    Oncologist; 2008; 13 Suppl 2():14-8. PubMed ID: 18434633
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of metastatic colon cancer by molecular targeting drugs].
    Sakamoto T; Machida N; Boku S
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1854-62. PubMed ID: 19058425
    [No Abstract]   [Full Text] [Related]  

  • 57. Adjuvant trials design in colon cancer.
    Hendlisz A; Golfinopoulos V
    Curr Opin Oncol; 2009 Jul; 21(4):367-8. PubMed ID: 19444100
    [No Abstract]   [Full Text] [Related]  

  • 58. [Groupe Européen de Chimiothérapie Anticancéreuse (G.E.C.A.). Protocol for clinical trials of treatments of leukemias and hematosarcomas].
    Eur J Cancer (1965); 1966 Feb; 2(1):85-8. PubMed ID: 5336133
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current topics of chemotherapy for sarcoma and bone neoplasms].
    Hirata T; Ando M
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):415-419. PubMed ID: 18401919
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.